carbon monoxide has been researched along with Diabetic Neuropathies in 4 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty patients with Type 1 diabetes, 20 with autonomic neuropathy according to the results of a standardized test battery, were studied and compared with 40 normal subjects matched by age and sex." | 1.37 | Pulmonary diffusing capacity for carbon monoxide: a marker of depressed hypercapnic drive in type 1 diabetes mellitus? ( Antonelli Incalzi, R; Contu, C; Fuso, L; Ghirlanda, G; Maugeri, L; Musella, T; Paladini, L; Pitocco, D; Santamaria, AP; Varone, F, 2011) |
| "The presence of diabetic nephropathy was determined by 24 h protein excretion." | 1.32 | Pulmonary functions in patients with type 2 diabetes mellitus & correlation with anthropometry & microvascular complications. ( Guleria, R; Misra, A; Pandey, RM; Sinha, S; Tiwari, S; Yadav, R, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vojtková, J | 1 |
| Ďurdík, P | 1 |
| Michnová, Z | 1 |
| Turčan, T | 1 |
| Čiljaková, M | 1 |
| Castany, S | 1 |
| Carcolé, M | 1 |
| Leánez, S | 1 |
| Pol, O | 1 |
| Fuso, L | 1 |
| Paladini, L | 1 |
| Pitocco, D | 1 |
| Musella, T | 1 |
| Contu, C | 1 |
| Maugeri, L | 1 |
| Santamaria, AP | 1 |
| Varone, F | 1 |
| Ghirlanda, G | 1 |
| Antonelli Incalzi, R | 1 |
| Sinha, S | 1 |
| Guleria, R | 1 |
| Misra, A | 1 |
| Pandey, RM | 1 |
| Yadav, R | 1 |
| Tiwari, S | 1 |
4 other studies available for carbon monoxide and Diabetic Neuropathies
| Article | Year |
|---|---|
Exhaled carbon monoxide in adolescents with diabetic cardiovascular autonomic neuropathy.
Topics: Adolescent; Biomarkers; Carbon Monoxide; Carboxyhemoglobin; Diabetes Mellitus, Type 1; Diabetic Neur | 2014 |
The role of carbon monoxide on the anti-nociceptive effects and expression of cannabinoid 2 receptors during painful diabetic neuropathy in mice.
Topics: Analgesics; Animals; Carbon Monoxide; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enzyme | 2016 |
Pulmonary diffusing capacity for carbon monoxide: a marker of depressed hypercapnic drive in type 1 diabetes mellitus?
Topics: Adult; Autonomic Nervous System Diseases; Carbon Monoxide; Case-Control Studies; Diabetes Mellitus, | 2011 |
Pulmonary functions in patients with type 2 diabetes mellitus & correlation with anthropometry & microvascular complications.
Topics: Adult; Analysis of Variance; Anthropometry; Carbon Monoxide; Diabetes Mellitus, Type 2; Diabetic Ang | 2004 |